Table 4.
Clinical Isolate | Resistance Phenotype a |
---|---|
Staphylococcus aureus ATCC 43300 | PEN (methicillin-resistant) |
Acinetobacter baumannii SI-12 | PEN, CARB (blaOXA-23+), AG, FQ, SXT |
Acinetobacter baumannii SI-310 | PEN, CARB (blaOXA-24+), AZT, AG, FQ, SXT, COL |
Acinetobacter baumannii SI-648 | PEN, CARB (blaOXA-23+ + hyperproduction of OXA-51-like enzyme), AG, FQ, SXT |
Pseudomonas aeruginosa VR-143/97 | PEN, ES-CEPH, CARB (blaVIM-1+), AZT, AG, FQ |
Pseudomonas aeruginosa VA-182/00 | PEN, ES-CEPH, CARB (blaVIM-2+), AZT, AG, FQ |
Pseudomonas aeruginosa 101/1477 | PEN, ES-CEPH, CARB (blaIMP-1+), AG |
Pseudomonas aeruginosa 506/99 | PEN, ES-CEPH, CARB (blaVIM-2+), AG |
a PEN, penicillins; ES-CEPH, expended-spectrum cephalosporins; CARB, carbapenems (the carbapenemase-encoding gene(s) found in the isolate is (are) indicated between parentheses), AZT, aztreonam (a monobactam); AG, aminoglycosides; FQ, fluoroquinolones; SXT, trimethoprim-sulfamethoxazole; FOS, fosfomycin; COL, colistin.